Form 13F-HR Indigo Partners LLC For: Mar 31
http://archive.fast-edgar.com/20240515/AB2BB222Z22252ZS222M2M43D6QSZK22Z262
Filed on: May 15, 2024
Form 6-K Bitfarms Ltd For: May 15
http://archive.fast-edgar.com/20240515/AN22K22CLZ229292229J2CY2S2CRM222Y262
Filed on: May 15, 2024
Form 6-K Borr Drilling Ltd For: May 15
http://archive.fast-edgar.com/20240515/AO2ZS22CZM22C2LU222M2242F8JHZC22ZC62
Filed on: May 15, 2024
Form 6-K KONINKLIJKE PHILIPS NV For: May 15
http://archive.fast-edgar.com/20240515/AU22B222E222A2Z2222G22YUJFGF32225262
Filed on: May 15, 2024
Form 10-Q Renalytix plc For: Mar 31
http://archive.fast-edgar.com/20240515/AA26B222ZZ22K25222TW2242O9KHZK22B262
Filed on: May 15, 2024
More SEC Filings
View Older Stories-
Form 10-Q SK Growth Opportunities For: Mar 31
-
Form 144 ASIAFIN HOLDINGS CORP. Filed by: SEE UNICORN VENTURES SDN BHD
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 14 Filed by: Doyle Anthony
-
Form 8-K UNITED STATES ANTIMONY For: May 15
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 14 Filed by: Thackray Helen M.
-
Form SC 13D/A ADAMS DIVERSIFIED EQUITY Filed by: Saba Capital Management, L.P.
-
Form 10-Q Venus Concept Inc. For: Mar 31
-
Form 10-Q TREVENA INC For: Mar 31
-
Form 8-K ATAI Life Sciences N.V. For: May 14
-
Form 6-K Sportradar Group AG For: May 15
-
Form 8-K Adaptimmune Therapeutics For: May 14
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Galson Steven K
-
Form 8-K BurgerFi International, For: May 15
-
Form 8-K Guerrilla RF, Inc. For: May 15
-
Form 13F-HR Arias Resource Capital For: Mar 31
-
Form 6-K Ayr Wellness Inc. For: May 15
-
Form 8-K Acurx Pharmaceuticals, For: May 15
-
Form 8-K Zapata Computing Holding For: May 15
-
Form 10-Q Volato Group, Inc. For: Mar 31
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Barnes Alane P
-
Form 8-K Edible Garden AG Inc For: May 15
-
Form 8-K BIO-PATH HOLDINGS, INC. For: May 15
-
Form 13F-NT Bank of Singapore Ltd For: Mar 31
-
Form 20-F Xinyuan Real Estate Co., For: Dec 31
-
Form 13F-HR ABG Innovation Capital For: Mar 31
-
Form 8-K Volato Group, Inc. For: May 15
-
Form 13F-HR Fullerton Fund Managemen For: Mar 31
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Stonehouse Jon P
-
Form 10-Q Katapult Holdings, Inc. For: Mar 31
-
Form 6-K ONCOLYTICS BIOTECH INC For: May 15
-
Form 8-K Olema Pharmaceuticals, For: May 15
-
Form 8-K TREVENA INC For: May 15
-
Form 8-K Venus Concept Inc. For: May 15
-
Form 6-K RADCOM LTD For: May 15
-
Form 8-K Cabaletta Bio, Inc. For: May 15
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Gayer Charles K
-
Form 13F-HR MUFG Securities EMEA For: Mar 31
-
Form 6-K Flex LNG Ltd. For: May 15
-
Form 6-K COMPUGEN LTD For: May 15
-
Form 8-K Perspective Therapeutics For: May 15
-
Form 10-K Prestige Consumer Health For: Mar 31
-
Form 13F-HR Fundsmith LLP For: Mar 31
-
Form 10-Q PSQ Holdings, Inc. For: Mar 31
-
Form 8-K Predictive Oncology Inc. For: May 15
-
Form 8-K Katapult Holdings, Inc. For: May 15
-
Form 8-K DecisionPoint Systems, For: May 15
-
Form 13F-NT Quilter Cheviot Internat For: Mar 31
-
Form 10-12B/A Inhibrx Biosciences,
-
Form 10-Q Eledon Pharmaceuticals, For: Mar 31
-
Form 10-Q Sagimet Biosciences Inc. For: Mar 31